Singular Genomics Systems, Inc. financial data

Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2024 - 12 Nov 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 925% % -46%
Quick Ratio 75% % -34%
Debt-to-equity 53% % 70%
Return On Equity -58% % -43%
Return On Assets -38% % -23%
Operating Margin -3489% % 9.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2,511,783 shares -97%
Common Stock, Shares, Outstanding 2,507,171 shares -97%
Common Stock, Value, Issued $0 USD -100%
Weighted Average Number of Shares Outstanding, Basic 2,501,093 shares 3.5%
Weighted Average Number of Shares Outstanding, Diluted 2,501,093 shares 3.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $2,666,000 USD 2.7%
Cost of Revenue $4,021,000 USD 48%
Research and Development Expense $43,480,000 USD -7.2%
Operating Income (Loss) $93,004,000 USD 7%
Net Income (Loss) Attributable to Parent $86,322,000 USD 6.9%
Earnings Per Share, Basic 3 USD/shares 27%
Earnings Per Share, Diluted 3 USD/shares 27%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $52,620,000 USD 58%
Cash, Cash Equivalents, and Short-term Investments $113,800,000 USD -40%
Inventory, Net $12,410,000 USD -7.5%
Assets, Current $129,810,000 USD -38%
Property, Plant and Equipment, Net $12,457,000 USD -7.2%
Operating Lease, Right-of-Use Asset $42,617,000 USD -27%
Other Assets, Noncurrent $1,067,000 USD 853%
Assets $186,551,000 USD -34%
Accounts Payable, Current $1,882,000 USD -23%
Accrued Liabilities, Current $4,887,000 USD -3.5%
Liabilities, Current $17,609,000 USD 14%
Operating Lease, Liability, Noncurrent $39,857,000 USD -33%
Other Liabilities, Noncurrent $666,000 USD -9.9%
Liabilities $63,298,000 USD -26%
Accumulated Other Comprehensive Income (Loss), Net of Tax $83,000 USD
Retained Earnings (Accumulated Deficit) $400,668,000 USD -27%
Stockholders' Equity Attributable to Parent $123,253,000 USD -38%
Liabilities and Equity $186,551,000 USD -34%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $23,703,000 USD -32%
Net Cash Provided by (Used in) Financing Activities $0 USD -100%
Net Cash Provided by (Used in) Investing Activities $31,579,000 USD -57%
Common Stock, Shares Authorized 400,000,000 shares 0%
Common Stock, Shares, Issued 2,507,171 shares
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $7,876,000 USD -86%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $53,220,000 USD 52%
Interest Paid, Excluding Capitalized Interest, Operating Activities $246,000 USD 14%
Operating Lease, Liability $45,326,000 USD -32%
Depreciation $1,019,000 USD 28%
Payments to Acquire Property, Plant, and Equipment $25,000 USD -85%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $86,025,000 USD 6%
Lessee, Operating Lease, Liability, to be Paid $74,516,000 USD -38%
Property, Plant and Equipment, Gross $23,568,000 USD 15%
Operating Lease, Liability, Current $5,469,000 USD -29%
Lessee, Operating Lease, Liability, to be Paid, Year Two $4,805,000 USD -16%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,369,000 USD -83%
Lessee, Operating Lease, Liability, to be Paid, Year Three $5,687,000 USD -34%
Lessee, Operating Lease, Liability, to be Paid, Year Four $5,572,000 USD -35%
Additional Paid in Capital $523,838,000 USD 2%
Share-based Payment Arrangement, Expense $2,165,000 USD -23%
Interest Expense $1,143,000 USD 8.1%